Free Trial

AIM ImmunoTech (AIM) Institutional Ownership

AIM ImmunoTech logo
$0.26
0.00 (0.00%)
(As of 11/1/2024 ET)

Institutional Ownership Changes (13F Filings) for AIM ImmunoTech (NYSE:AIM)

Current
Institutional Ownership
Percentage
12.02%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$1.52M
Number of
Institutional Sellers
(last 12 months)
0
Get AIM Insider Trade Alerts

Want to know when executives and insiders are buying or selling AIM ImmunoTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AIM Institutional Buying and Selling by Quarter

AIM ImmunoTech Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2024Armistice Capital LLC4,078,000$1.52M0.0%N/A7.919%
11/16/2021Verition Fund Management LLC148,479$300K0.0%+37.5%0.310%
11/15/2021HighTower Advisors LLC41,095$82K0.0%-38.8%0.086%
10/28/2021WINTON GROUP Ltd82,564$167K0.0%+50.4%0.173%
10/19/2021 Arkadios Wealth Advisors21,597$43K0.0%N/A0.045%
8/17/2021Bridgeway Capital Management LLC246,000$529K0.0%-9.2%0.514%
8/16/2021Schonfeld Strategic Advisors LLC23,100$49K0.0%-40.0%0.048%
8/16/2021State Street Corp160,413$345K0.0%N/A0.335%
8/13/2021Renaissance Technologies LLC152,848$329K0.0%-68.1%0.320%
8/13/2021Northern Trust Corp87,226$188K0.0%+28.8%0.182%
8/13/2021Vanguard Group Inc.1,993,156$4.29M0.0%+3.5%4.167%
8/12/2021XTX Topco Ltd29,269$63K0.0%N/A0.061%
8/12/2021Dimensional Fund Advisors LP139,160$299K0.0%N/A0.291%
8/10/2021WINTON GROUP Ltd54,894$118K0.0%N/A0.115%
6/4/2021Lehman & Derafelo Financial Resources LLC11,100$25K0.0%N/A0.023%
5/19/2021Virtu Financial LLC29,484$67K0.0%-71.6%0.062%
5/18/2021Verition Fund Management LLC108,000$245K0.0%+80.0%0.226%
5/18/2021Morgan Stanley2,505,954$5.69M0.0%+150.9%5.240%
5/18/2021Citadel Advisors LLC103,283$234K0.0%N/A0.216%
5/17/2021Schonfeld Strategic Advisors LLC38,500$88K0.0%N/A0.081%
5/13/2021Renaissance Technologies LLC478,759$1.09M0.0%N/A1.001%
5/12/2021Geode Capital Management LLC351,750$798K0.0%+49.7%0.736%
5/11/2021Rockefeller Capital Management L.P.40,000$90K0.0%+100.0%0.084%
5/10/2021HighTower Advisors LLC63,095$143K0.0%N/A0.132%
5/10/2021GSA Capital Partners LLP74,790$170K0.0%+338.7%0.156%
5/7/2021BlackRock Inc.979,042$2.22M0.0%+91.7%2.047%
5/7/2021 Cambridge Investment Research Advisors Inc.46,679$106K0.0%+14.7%0.098%
5/4/2021Community Bank N.A.13,226$30K0.0%N/A0.028%
4/21/2021Lehman & Derafelo Financial Resources LLC11,100$25K0.0%N/A0.023%
2/24/2021Virtu Financial LLC103,807$186K0.0%+250.7%0.255%
2/18/2021Verition Fund Management LLC60,000$107K0.0%+50.0%0.147%
2/5/2021BlackRock Inc.510,796$914K0.0%+1.6%1.255%
2/4/2021 Cambridge Investment Research Advisors Inc.40,679$73K0.0%+19.0%0.100%
2/4/2021GSA Capital Partners LLP17,047$31K0.0%-82.2%0.042%
12/11/2020Virtu Financial LLC29,604$64K0.0%-55.5%0.073%
11/13/2020Morgan Stanley805,415$1.73M0.0%+69.1%2.029%
11/12/2020JPMorgan Chase & Co.17,369$37K0.0%+868,350.0%0.044%
11/10/2020 Arkadios Wealth Advisors20,000$45K0.0%N/A0.050%
11/9/2020LPL Financial LLC20,500$44K0.0%N/A0.052%
11/6/2020BlackRock Inc.502,692$1.08M0.0%+5.7%1.267%
I was wrong. Dead wrong. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

11/6/2020GSA Capital Partners LLP95,754$206K0.0%N/A0.241%
10/29/2020 Cambridge Investment Research Advisors Inc.34,179$73K0.0%N/A0.086%
(Data available from 1/1/2016 forward)

AIM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AIM shares?

During the previous two years, the following institutional investors and hedge funds held shares of AIM ImmunoTech shares: Armistice Capital LLC ($1.52M).Learn more on AIM's institutional investors.

What percentage of AIM ImmunoTech stock is owned by institutional investors?

12.02% of AIM ImmunoTech stock is owned by institutional investors. Learn more on AIM's institutional investor holdings.

Which institutional investors have been buying AIM ImmunoTech stock?

The following institutional investors have purchased AIM ImmunoTech stock in the last 24 months: Armistice Capital LLC ($4.08M).

How much institutional buying is happening at AIM ImmunoTech?

Institutional investors have bought a total of 4,078,000 shares in the last 24 months. This purchase volume represents approximately $1.52M in transactions.



This page (NYSE:AIM) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners